University of Chicago
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Chicago sits in the top decile of US sponsors by registered trial count (#41 of 15,742 sponsors by registered trial count).
University of Chicago: 796 sponsored US clinical trials, 158 recruiting.
University of Chicago sponsors 796 registered US clinical trials on ClinicalTrials.gov, 158 of them currently recruiting, and 451 completed. 67 of these trials are in Phase 3-4 (later-stage) and 293 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 11 trials.
Top-decile sponsor footprint
University of Chicago ranks in the top decile of sponsors by registered trial count (#41 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
451 of 562 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (80.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
796 total, page 11 of 16
Vandetanib in Preventing Head and Neck Cancer in Patients With Precancerous Head and Neck Lesions
NCT01414426
Asymptomatic Colonization With S. Aureus After Therapy With Linezolid or Clindamycin for Acute Skin Infections
NCT01619410
Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete Remission
NCT01842139
Nab-paclitaxel (Abraxane) With or Without Mifepristone in Patients With Advanced Breast Cancer
NCT01493310
The Efficacy of Claritin in Healthy Subjects
NCT01451996
A Study of Ranolazine Acute Administration and Short Term Administration in Pulmonary Arterial Hypertension
NCT01757808
Effectiveness of Interventions to Teach Respiratory Inhaler Technique (E-TRaIN)
NCT01426581
Early Mobilization in the ICU
NCT01777035
Stem Cell Transplantation for Patients With Multiple Myeloma
NCT01526096
Evaluating the Patient-Ventilator Synchrony During Mechanical Ventilation in Patients With Acute Lung Injury
NCT01541514
Personalized Decision Support for Older Patients With Diabetes
NCT02169999
Feasibility of Imaging in the Treatment of Patients With Advanced Head and Neck Cancer
NCT01359267
Health and Faith (Salud y Fe): Community-Based Diabetes Pilot Intervention
NCT01288300
Effects of Allergic Rhinitis on the Nasal/Sinus Microbiome
NCT01461200
Impact of Exenatide on Sleep Duration
NCT01416649
Comparison of Two Lidocaine Administration Techniques
NCT01330134
Observational Study of Blood Pressure Measurements and Continuous Dialysis
NCT01286506
NasoNeb Delivery of an Intranasal Steroid
NCT01270256
Non-cancer Pain and Cognitive Impairment: A Disabling Relationship
NCT01264965
Impact of Coronary Images Used During Patient Education on Coronary Artery Disease and Subsequent Lifestyle Modifications. Is a Picture Really Worth a Thousand Words?
NCT01275716
Bacterial Microbiota In The Tonsils Of Children
NCT01270243
Drug Effects on Preference and Reward
NCT01722006
The Effect of Loop Diuretics on Severity and Outcome of Acute Kidney Injury
NCT01275729
Prevalence Of Internal Pudendal Artery Disease In Patients With Erectile Dysfunction Undergoing Diagnostic Coronary Angiography
NCT01276145
Thirty Million Words Project: A Feasibility Trial
NCT01754077
Selective Serotonin Reuptake Inhibitors (SSRIs) in Borderline Personality Disorder
NCT01103180
Single Shot vs Continuous Interscalene Block for Rotator Cuff Repair
NCT01122745
Comparison of Pain Relief After Non Stimulating Interscalene Catheter Placement vs Stimulating Catheter Placement in Total Shoulder Arthroplasty.
NCT01122732
Effects of MDMA on Social and Emotional Processing
NCT01849419
In Vivo nCLE Study in the Pancreas With Endosonography of Cystic Tumors
NCT01236300
A Study of Pre-Operative Treatment of Newly-Diagnosed, Surgically-Resectable Osteosarcoma With Doxorubicin, Ifosfamide, Etoposide, and Cisplatin With Early Metabolic Assessment of Response
NCT01258634
Effect of Montelukast Therapy in Obstructive Sleep Apnea(OSA) Children
NCT01027806
Impact of Exenatide on Sleep in Type 2 Diabetes
NCT01136798
Patient Satisfaction and Safety Outcomes After Enrollment in a Same-Day (SD) Percutaneous Coronary Intervention Program
NCT01276132
Delirium in Mechanically Ventilated Patients
NCT00919698
Vitamin D Plus Fluticasone Propionate
NCT01103934
Study in Locally Advanced Squamous Cell Carcinoma of Head and Neck
NCT01133678
Antiplatelet Response, Interval Variability & Events in Percutaneous Coronary Intervention (ARIVE-PCI) Registry
NCT01278043
A Pilot Study of Chemo-prevention of Green Tea in Women With Ductal Carcinoma in Situ
NCT01060345
Tysabri Effects on Cognition and Neurodegeneration in Multiple Sclerosis
NCT01071512
Marinol in Trichotillomania or Obsessive Compulsive Disorder
NCT01093976
Unattended In-home Sleep Recording: A Pilot Study
NCT01102842
Everolimus Versus Placebo in Head and Neck Cancer
NCT01111058
Cord Blood Transplantation for Patients With Cancer
NCT01359254
Partial Wave Spectroscopic Detection of Colon Cancer Risk
NCT01095432
Dose Escalation of Bevacizumab With Ambulatory Blood Pressure Monitoring in Patients With Advanced Non-squamous NSCLC
NCT01063283
To Determine if a Lower Extremity Strengthening Program Improve Quadriceps Muscle Strength
NCT01080703
Cetuximab and Lenalidomide in Head and Neck
NCT01133665
Dose Escalation Study of RAD001 in Combination w/Chemotherapy & Radiation in Patients With NSCLC
NCT01063478
Topical ASP-1001 (Contrast Media Formulation) and the Acute Response to Nasal Allergen Challenge (NAC)
NCT00791102
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 137 |
| Phase 2 | 156 |
| Phase 3 | 14 |
| Phase 4 | 53 |
Therapeutic Areas
What is open in the University of Chicago pipeline
158 recruiting of 796 indexed (20% open); 451 completed (57%).
Phase mix: 67 late (III/IV) vs 293 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (11 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Chicago: open-pipeline peers nationwide
Peers matched on 796 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
University of Chicago sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 796 trials (± recruiting share)
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
- University of California, San Diego · 775 trials · 18% recruiting
- University of Utah · 818 trials · 17% recruiting
- University of Texas Southwestern Medical Center · 837 trials · 19% recruiting
Sponsors near 20% open enrollment (± trial volume)
- Acera Surgical · 20% recruiting · 5 trials
- Align Technology · 20% recruiting · 5 trials
- AltruBio · 20% recruiting · 5 trials
- Alvernia University · 20% recruiting · 5 trials
Related
What to do with this University of Chicago page
796 registered trials is a research-attention snapshot, not an endorsement of University of Chicago or any single study.
- 158 of University of Chicago's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition University of Chicago studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Chicago pipeline card: 796 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.